Document is current
Any future updates will be listed below
-
Authors
Goetzke, F. Wieland https://orcid.org/0000-0002-8688-5609
Bernard, Steffen M. https://orcid.org/0000-0001-8061-6136
Ju, Cheng-Wei https://orcid.org/0000-0002-2250-8548
Pollock, Jonathan
DeMeester, Kristen E.
Gross, Jacob
Simon, Gabriel M.
He, Chuan https://orcid.org/0000-0003-4319-7424
Melillo, Bruno https://orcid.org/0000-0002-9708-5287
Cravatt, Benjamin F. https://orcid.org/0000-0001-5330-3492
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35 CA231991)
- License Information
-
More Information
Article History
Received: 26 May 2025
Accepted: 11 November 2025
First Online: 8 January 2026
Competing interests
: S.M.B., J.P., J.G. and G.M.S. are employees of Vividion Therapeutics, and B.F.C. is a founder and member of the board of directors of Vividion Therapeutics. The other authors declare no competing interests.
